The Efficacy of Inositol and N-Acetyl Cysteine Administration (Ovaric HP) in Improving the Ovarian Function in Infertile Women with PCOS with or without Insulin Resistance.
Angela SacchinelliRoberta VenturellaDaniela LicoAnnalisa Di CelloAntonella LuciaErika RaniaRoberto CirilloFulvio ZulloPublished in: Obstetrics and gynecology international (2014)
Objective. Substances such as inositol and N-acetylcysteine (NAC) have been recently shown to be effective in treatment of PCOS patients. The aim of this prospective trial is to evaluate the efficacy of NAC + Inositol + folic acid on ovulation rate and menstrual regularity in PCOS patients with and without insulin resistance. Methods. Among the 91 PCOS patients treated with NAC + Inositol + folic, insulin resistance was present in 44 subjects (A) and absent in 47 (B). The primary endpoint was the ovulation rate/year, determined by menstrual diary, serum progesterone performed between 21° and 24° days, ultrasound findings of growth follicular or luteal cysts, and luteal ratio. HOMA-index assessment after 6 and 12 months of treatment was evaluated as secondary endpoint. Results. In both groups there was a significant increase in ovulation rate and no significant differences were found in the primary outcome between two groups. In group A, a significant reduction of HOMA-index was observed. Conclusions. The association NAC + Inositol + folic, regardless of insulin-resistance state, seems to improve ovarian function in PCOS patients. Therefore, inositol and NAC may have additional noninsulin-related mechanisms of action that allow achieving benefits also in those patients with negative HOMA-index.
Keyphrases
- polycystic ovary syndrome
- insulin resistance
- transcription factor
- metabolic syndrome
- adipose tissue
- end stage renal disease
- high fat diet
- skeletal muscle
- ejection fraction
- type diabetes
- chronic kidney disease
- prognostic factors
- high fat diet induced
- peritoneal dialysis
- patient reported outcomes
- clinical trial
- single molecule
- weight loss
- drinking water
- double blind
- replacement therapy